ZA64 25 mg
Pill imprint ZA64 25 mg has been identified as Topiramate (sprinkle) 25 mg.
Topiramate is used in the treatment of migraine prevention; seizure prevention; bipolar disorder; smoking cessation; obesity (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy.
Topiramate 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Topiramate (sprinkle) Images
- Imprint:
-
ZA64
25 mg - Strength:
- 25 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- cellulose acetate
hypromelloses
gelatin
povidone
sodium lauryl sulfate
sucrose
magnesium silicate
titanium dioxide
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Zydus Pharmaceuticals
- National Drug Code (NDC):
- 68382-0005
Advertisement
More Topiramate (Sprinkle) resources
- Topiramate (Wolters Kluwer)
- Topiramate Sprinkle Capsules (Wolters Kluwer)
- topiramate (Cerner Multum)
- topiramate (Micromedex) - Includes Dosage Information
- Topiramate (AHFS DI)
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate (Wolters Kluwer)
Search Again
